1. Revenue $10,010,986 Increase of 23%2. PE Ratio 11.523. PE...

1. Revenue $10,010,986 Increase of 23%

2. PE Ratio 11.52

3. PE Industry Group Average 13.36

4. Profit after income tax $931,326 Loss from previous Period $10,817,136

5. Cash in bank $1,796m and increase of $761,490 over the previous period.

6. Assets increased by 10% Liabilities decreased by 19%

7. EPS (cps) .27

8. Financial Position STRONG.

9. SP Triggers. Substantial announcements in pipeline.

10. Strategy. Accumulate at current levels.

Overview

increase and diversify sales both geographically and by product;
increase manufacturing efficiencies and reduce manufacturing costs;
reduce expenses and overheads;
restructure staffing and distribution agreements to focus on driving shareholder returns;
in partnership with CSIRO, pursue opportunities to commercialise the unique intellectual property
within the DataTraceDNA Pty Limited joint venture; and
establish partnerships which take DataDot technology into new applications.

Summary.

Revenue stream is ongoing as it is created.

Massive upside with new expanded customer diversification, guaranteeing an ever increasing income stream.

Costs now under control.

Product develop continues with highly creditable partner in CSIRO

Future looks bright!